Jiaxiong Wang

Mr. Jiaxiong Wang

Center of reproduction and genetics, Suzhou Municipal Hospital, Suzhou, Anhui, China
+1
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2017 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
STShuyan Tang
Shuyan Tang
XWXiong Wang
Xiong Wang
WLWeiyu Li
Weiyu Li
XYXiaoyu Yang
Xiaoyu Yang
ZLZheng Li
Zheng Li
FZFeng Zhang
Feng Zhang

1 February 2021 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
CLChunyu Liu
Chunyu Liu
CTChaofeng Tu
Chaofeng Tu
LWLingbo Wang
Lingbo Wang
HWHuan Wu
Huan Wu
BHBrendan J. Houston
Brendan J. Houston
FZFeng Zhang
Feng Zhang

5 December 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
XZXing Zhang
Xing Zhang
JGJing Guo
Jing Guo
SFShufeng Fan
Shufeng Fan
YLYanyuan Li
Yanyuan Li
LWLiliang Wei
Liliang Wei
JLJi-Cheng Li
Ji-Cheng Li
It is very difficult to prevent pulmonary tuberculosis (TB) due to the lack of specific and diagnostic markers, which could lead to a high incidence of pulmonary TB. We screened the differentially expressed serum microRNAs (miRNAs) as potential biomarkers for the diagnosis of pulmonary TB. In this study, serum miRNAs were screened using the Solexa sequencing method as the potential biomarkers for the diagnosis of pulmonary TB. The stem-loop quantitative reverse-transcription polymerase chain reaction (qRT-PCR) assay was used to verify differentially expressed serum miRNAs. The receiver operating characteristic (ROC) curve and logistic regression model were used to analyze the sensitivity and specificity of the single miRNA and a combination of miRNAs for diagnosis, respectively. Using the predicted target genes, we constructed the regulatory networks of miRNAs and genes that were related to pulmonary TB. The Solexa sequencing data showed that 91 serum miRNAs were differentially expressed in pulmonary TB patients, compared to healthy controls. Following qRT-PCR confirmation, six serum miRNAs (hsa-miR-378, hsa-miR-483-5p, hsa-miR-22, hsa-miR-29c, hsa-miR-101 and hsa-miR-320b) showed significant difference among pulmonary TB patients, healthy controls (P<0.001) and differential diagnosis groups (including patients with pneumonia, lung cancer and chronic obstructive pulmonary disease) (P<0.05). The logistic regression analysis of a combination of six serum miRNAs revealed that the sensitivity and the specificity of TB diagnosis were 95.0% and 91.8% respectively. The miRNAs-gene regulatory networks revealed that several miRNAs may regulate some target genes involved in immune pathways and participate in the pathogenesis of pulmonary TB. Our study suggests that a combination of six serum miRNAs have great potential to serve as non-invasive biomarkers of pulmonary TB.

1 April 2019 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
WLWangjie Liu
Wangjie Liu
XHXiaojin He
Xiaojin He
SYShenmin Yang
Shenmin Yang
RZRaoudha Zouari
Raoudha Zouari
Jiaxiong WangJiaxiong Wang
Jiaxiong Wang
FZFeng Zhang
Feng Zhang

1 December 2019 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
CLChunyu Liu
Chunyu Liu
XHXiaojin He
Xiaojin He
WLWangjie Liu
Wangjie Liu
SYShenmin Yang
Shenmin Yang
LWLingbo Wang
Lingbo Wang
FZFeng Zhang
Feng Zhang

1 January 2012 in International Journal of Biological Sciences
Verified
Journal Article
Open access
XLXiang Li
Xiang Li
Jiaxiong WangJiaxiong Wang
Jiaxiong Wang
ZYZaiyuan Ye
Zaiyuan Ye
JLJi-Cheng Li
Ji-Cheng Li
Background: Oridonin (ORI) could inhibit the proliferation and induce apoptosis in various cancer cell lines. However, the mechanism is not fully understood.